Responsive image

Common name


4-amino-N-methyl-benzamide

IUPAC name


4-amino-N-methyl-benzamide

SMILES


Nc1ccc(cc1)C(=O)NC

Common name


4-amino-N-methyl-benzamide

IUPAC name


4-amino-N-methyl-benzamide

SMILES


Nc1ccc(cc1)C(=O)NC

INCHI


InChI=1S/C8H10N2O/c1-10-8(11)6-2-4-7(9)5-3-6/h2-5H,9H2,1H3,(H,10,11)

FORMULA


C8H10N2O

Responsive image

Common name


4-amino-N-methyl-benzamide

IUPAC name


4-amino-N-methyl-benzamide





Molecular weight


150.178

clogP


0.648

clogS


-1.802

Frequency


0.0007





HBond Acceptor


1

HBond Donor


3

Total Polar
Surface Area


55.12

Number of Rings


1

Rotatable Bond


1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00888 Procainamide Responsive image Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ia; CYP2D6 Inducers; CYP2D6 Inducers (strong); For the treatment of life-threatening ventricular arrhythmias.
FDBD01405 Amisulpride Responsive image Antipsychotic Agents; Dopamine Antagonists; Nervous System; Psycholeptics; Benzamides; Investigated for use/treatment in schizophrenia and schizoaffective disorders, mania in bipolar disorder, and depression.
2 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
1lf2_ligand_2_70.mol2 1lf2 1 -6.69 CNC(=O)c1ccc(cc1)N 11
2vgp_ligand_2_2.mol2 2vgp 1 -6.50 Nc1ccc(C(=O)NC)cc1 11
4bb4_ligand_3_2.mol2 4bb4 1 -6.39 c1(ccc(cc1)N)C(=O)NC 11
1rww_ligand_3_52.mol2 1rww 1 -6.19 Nc1ccc(cc1)C(=O)NC 11
4r7m_ligand_2_0.mol2 4r7m 1 -6.06 C(=O)(NC)c1ccc(cc1)N 11
1lf2_ligand_3_268.mol2 1lf2 0.902439 -6.95 C(C)NC(=O)c1ccc(cc1)N 12
1lf2_ligand_3_277.mol2 1lf2 0.902439 -6.91 C(C)NC(=O)c1ccc(cc1)N 12
4bb4_ligand_4_1.mol2 4bb4 0.902439 -6.46 c1(ccc(cc1)N)C(=O)NCC 12
1lf2_ligand_4_701.mol2 1lf2 0.880952 -7.26 C(C)(C)NC(=O)c1ccc(cc1)N 13
2oym_ligand_3_0.mol2 2oym 0.880952 -6.96 CNC(=O)c1ccc(N(C)C)cc1 13
200 , 21